Premium
Sex Differences in Prevalence, Symptoms, Impact, and Psychiatric Comorbidities in Migraine and Probable Migraine: A Population‐Based Study
Author(s) -
Song TaeJin,
Cho SooJin,
Kim WonJoo,
Yang Kwang Ik,
Yun ChangHo,
Chu Min Kyung
Publication year - 2019
Publication title -
headache: the journal of head and face pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 119
eISSN - 1526-4610
pISSN - 0017-8748
DOI - 10.1111/head.13470
Subject(s) - migraine , medicine , population , interquartile range , prevalence , psychiatry , international classification of headache disorders , demography , pediatrics , environmental health , sociology
Objective This study was conducted to investigate sex differences in the prevalence and clinical presentation of migraine and probable migraine in a general population‐based sample. Background While there is research on sex differences in clinical characteristics and their impact on migraine headache, only few studies have investigated sex differences in probable migraine in population‐based settings. Moreover, compared with Western countries, the prevalence of probable migraine in Asia is relatively high. This cross‐sectional study was designed to investigate sex differences in the prevalence and clinical presentation of migraine and probable migraine in a general population‐based sample. Methods We used the data of the Korean Headache‐Sleep Study, which is a nationwide survey on headache and sleep. Results We interviewed 7430 people, and 3114 of them agreed to participate in our study (rejection rate, 58.1%). Among these people, 419 withdrew their participation during the interview. Ultimately, 2695 people completed our survey (cooperation rate, 36.3%). The prevalence of overall migraine and probable migraine was 350/1350 (25.9%) for women and 172/1345 (12.8%) for men ( P < .001, respectively). The prevalence of migraine (107/1350 [7.9%] vs 36/1345 [2.7%], P < .001) and probable migraine (243/1350 [18.0%] vs 136/1345 [10.1%], P < .001) was significantly higher among women than among men. Headache frequency per month (median [interquartile range]) (1.0 [0.3–3.0] vs 0.8 [0.3–2.0], P = .037), the visual analog scale score for headache intensity (5.0 [4.0–7.0] vs 5.0 [3.0–6.0], P = .019), and the impact of headache {Headache Impact Test‐6 score (47.0 [42.0–54.0] vs 44.0 [42.0–51.8], P = .013)} were significantly higher among women with probable migraine than men. Headache frequency per month (2.0 [0.4–4.0] vs 1.0 [0.3–2.0], P = .073), headache intensity (6.0 [5.0–8.0] vs 6.0 [4.2–7.0], P = .281), and the impact of headache (55.0 [48.0–61.0] vs 49.0 [46.3–60.8], P = .225) were not significantly different between women and men with migraine. Other comorbidities or associated symptoms, such as anxiety and depression, were not significantly different between women and men with migraine and probable migraine, except for nausea in probable migraine. Conclusion Women experience more severe symptoms and a higher impact of headache than men among participants with probable migraine. Our findings suggest that women with PM need a more intensive evaluation and treatment than men with PM.